focus -WSS

focus

author：fashion 2025-10-02 00:41:54 - browse：519

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company amid a wave of consumer complaints about patients receiving incorrect medicines or being unable to get their prescriptions filled.

Elevance did not confirm Marchetti’s departure as the president of CarelonRx, but according to his Linkedin profile, he left the company in May.

Elevance, the second-largest commercial health insurer in the country by market share, uses its CarelonRx subsidiary to manage its pharmacy business. In online complaints, CarelonRx customers point toward January 1 as the date when issues with obtaining their prescriptions from the company began. The reported problems include safety issues like receiving other people’s medications or receiving medications they discontinued years ago.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Getting Alzheimer's drug Leqembi to patients can be a challenge

knowledge

WSS

He's 19 months old and has one of the world’s rarest diseases

H5N1 bird flu virus started spreading in cows in Texas in December

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Diversity in clinical trials starts with building trust, experts say

Harvard's David Sinclair gets blowback over aging

The public health thinking behind the CDC’s new Covid guidance

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

focus

At least 13 dead in Texas as scorching temps continue

First over

Medical leaders decry Supreme Court decision on affirmative action

After traumatic brain injury, life support decisions can use more time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Ozempic has benefits for kidney disease as well as diabetes

Sports medicine is finally prioritizing gender equality

Cell therapy fails to slow type 1 diabetes, but safety is established

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Ancient Greek ideas underpin modern concepts of pregnancy

entertainment

Stem cell biologist probes earliest stages of human development

H5N1 bird flu found in pasteurized milk: what we know

Cholera vaccine supply gets boost as demand surges globally

Cholera vaccine supply gets boost as demand surges globally

More tobacco lobbyists active in statehouses

Stem cell biologist probes earliest stages of human development

knowledge

hotspot

hotspot

leisure time